BMSSC
RVMD icon

B. Metzler seel. Sohn & Co’s Revolution Medicines RVMD Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
13,605
+1,547
+13% +$226K 0.02% 372
2026
Q1 		$1.17M Sell
12,058
-5,382
-31% -$543K 0.01% 506
2025
Q4 		$1.39M Sell
17,440
-8,381
-32% -$550K 0.01% 481
2025
Q3 		$1.21M Hold
25,821
– – 0.01% 504
2025
Q2 		$950K Hold
25,821
– – 0.01% 558
2025
Q1 		$913K Buy
25,821
+8,622
+50% +$350K 0.01% 544
2024
Q4 		$752K Buy
+17,199
New +$868K 0.01% 587

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

B. Metzler seel. Sohn & Co's RVMD Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Revolution Medicines (RVMD) stake by 13% in Q2 2026, buying an estimated $226K and bringing the position to 13,605 shares worth $2.55M. The position accounts for 0.02% of the portfolio, ranked #372.

B. Metzler seel. Sohn & Co first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 13,605 shares of Revolution Medicines worth $2.55M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 1,547 Revolution Medicines shares in Q2 2026, an estimated $226K.
  • Revolution Medicines made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #372 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.